BioSpace News Archive

Press Releases

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 8, 2025

October 9, 2025
·
5 min read
Press Releases

Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025

October 9, 2025
·
4 min read
Press Releases

Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer

October 9, 2025
·
6 min read
Press Releases

ARS Pharmaceuticals Receives Favorable Decision from European Patent Office on Patent Related to neffy® (epinephrine nasal spray)

October 9, 2025
·
8 min read
Press Releases

Ashvattha Therapeutics to Present Phase 2 DME and nAMD Data at Innovate Retina

October 9, 2025
·
2 min read
Press Releases

Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome

October 9, 2025
·
4 min read
Press Releases

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS

October 9, 2025
·
5 min read
Press Releases

Hoth Therapeutics Expands Artificial Intelligence Initiative, Selects NVIDIA AI Enterprise Platform

October 9, 2025
·
5 min read
Press Releases

TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company

October 9, 2025
·
10 min read
Press Releases

CREATE Medicines Strengthens Executive Team with Appointment of Veteran Biopharma Leader Allan L. Shaw as CFO and CBO

October 9, 2025
·
3 min read